Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirect Line Regulatory News (DLG)

Share Price Information for Direct Line (DLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 200.40
Bid: 198.80
Ask: 199.30
Change: -2.00 (-0.99%)
Spread: 0.50 (0.252%)
Open: 203.40
High: 205.00
Low: 198.10
Prev. Close: 202.40
DLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Ageas SA/NV Securities

13 Mar 2024 09:00

RNS Number : 6643G
Direct Line Insurance Group PLC
13 March 2024
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Direct Line Insurance Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Ageas SA/NV

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

11 March 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes - Direct Line Insurance Group plc

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests held by the directors of Direct Line Insurance Group plc and their close relatives and related trusts

 

Name

Number of ordinary shares

% of total issued share capital (excluding share options)

N/A

N/A

N/A

 

(b) Interests held as options or awards under the share plans of Direct Line Insurance Group plc by the directors of Direct Line Insurance Group plc and their close relatives and related trusts who are not exempt principal traders for the purposes of Rule 8 of the Code

 

Name

Share Plan

Total options/awards outstanding

N/A

N/A

N/A

 

(c) Interests held and short positions held by connected advisers of Direct Line Group plc

 

Name

Security

Number

Short positions

% of total issued share capital (excluding share options)

Goldman Sachs & Co. LLC

Ordinary shares and ADRs

292

3

Gross long position: 0.00%

Gross short position: 0.00%

Goldman Sachs Bank Europe SE

Ordinary shares

726

333,341

Gross long position: 0.00%

Gross short position: 0.18%

Fundlogic SAS

Ordinary shares

10,833

0

Gross long position: 0.01%

Gross short position: 0.00%

Calvert Research & Management

Ordinary shares

8,907

0

Gross long position: 0.01%

Gross short position: 0.00%

Eaton Vance Management

Ordinary shares

23,255

0

Gross long position: 0.01%

Gross short position: 0.00%

Morgan Stanley Europe SE

Stock-settled derivatives - Call Option

1,200

-200

Gross long position: 0.00%

Gross short position: 0.00%

Stock-settled derivatives - Put Option

800

-1,900

Gross long position: 0.00%

Gross short position: 0.00%

 

Other than as set out above, no interests, short positions or rights to subscribe are held by Direct Line Insurance Group plc's connected advisers, or the persons affiliated with them, who are not exempt principal traders for the purposes of the Rule 8 of the Code.

 

(d) Interests, short positions and rights to subscribe held by other presumed concert parties of Direct Line Group plc

 

Name

Number of ordinary shares

% of total issued share capital (excluding share options)

N/A

N/A

N/A

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

No

Supplemental Form 8 (SBL)

No

 

 

Date of disclosure:

12 March 2024

Contact name:

Roger Clifton, Company Secretary

Telephone number:

+44 (0) 7710 179939

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEGRGDXDUBDGSX
Date   Source Headline
31st Aug 20236:00 pmRNSDirectorate Change
30th Aug 20234:00 pmRNSDirector/PDMR Shareholding
30th Aug 20237:00 amRNSAppointment of CEO
28th Jul 20234:00 pmRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSResponse to press coverage
28th Jun 20232:00 pmRNSDirector/PDMR Shareholding
1st Jun 20235:00 pmRNSNotice of Results
31st May 20233:00 pmRNSDirector/PDMR Shareholding
30th May 20236:30 pmRNSDirector/PDMR Shareholding
30th May 20235:30 pmRNSDirector/PDMR Shareholding
12th May 20233:30 pmRNSDirector/PDMR Shareholding
9th May 20233:00 pmRNSResult of AGM
9th May 20237:00 amRNSTrading Update for Q1 2023
28th Apr 20233:00 pmRNSDirector/PDMR Shareholding
25th Apr 20235:00 pmRNSHolding(s) in Company
14th Apr 20234:00 pmRNSHolding(s) in Company
3rd Apr 20234:15 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:00 pmRNSNotice of 2023 AGM
31st Mar 20233:00 pmRNSHolding(s) in Company
31st Mar 20232:30 pmRNS2022 Solvency and Financial Condition Report
30th Mar 20233:00 pmRNSAppointment to Board Committees
28th Mar 20233:30 pmRNSDirector/PDMR Shareholding
28th Mar 20233:30 pmRNSDirector/PDMR Shareholding
24th Mar 20239:30 amRNS2022 Annual Report and Accounts
20th Mar 20234:00 pmRNSHolding(s) in Company
14th Mar 20236:30 pmRNSHolding(s) in Company
13th Mar 20237:00 amRNSPreliminary Results year ended 31 December 2022
10th Mar 202310:15 amRNSDirector Declaration
1st Mar 20235:00 pmRNSHolding(s) in Company
28th Feb 20234:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20236:15 pmRNSHolding(s) in Company
17th Feb 20237:00 amRNSDirectorate Change
15th Feb 20237:00 amRNSNotice of 2022 preliminary results
30th Jan 20233:00 pmRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSDirectorate Change
26th Jan 20237:00 amRNSDirect Line Group executes strategic reinsurance
16th Jan 20236:00 pmRNSHolding(s) in Company
12th Jan 20233:00 pmRNSHolding(s) in Company
11th Jan 20237:00 amRNSTrading Update
29th Dec 202212:00 pmRNSDirector/PDMR Shareholding
13th Dec 20224:00 pmRNSHolding(s) in Company
12th Dec 20227:00 amRNSIFRS 17 update
29th Nov 20224:30 pmRNSDirector/PDMR Shareholding
29th Nov 20224:30 pmRNSDirector/PDMR Shareholding
18th Nov 20224:00 pmRNSHolding(s) in Company
11th Nov 20223:00 pmRNSHolding(s) in Company
8th Nov 20227:00 amRNSTrading Update for Q3 2022
28th Oct 20225:30 pmRNSDirector/PDMR Shareholding
10th Oct 202211:30 amRNSChange of Auditor
28th Sep 20226:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.